Search

Your search keyword '"Baki, Márta"' showing total 10 results
Start Over Author "Baki, Márta"
10 results on '"Baki, Márta"'

7. [Chemo- and radiotherapy of germ cell testicular cancer in the literature].

Author

Baki M, Takácsi Nagy L, and Mayer A

Subjects
Chemotherapy, Adjuvant, Germinoma secondary, Humans, Male, Neoplasm Staging, Prognosis, Radiotherapy, Adjuvant, Testicular Neoplasms pathology, Germinoma drug therapy, Germinoma radiotherapy, Testicular Neoplasms drug therapy, Testicular Neoplasms radiotherapy
Abstract

The study reviews the incidence, histologic types and prognostic factors of testicular cancer. The measurement of tumor-marker levels before castration determine the further activity regarding the data of imagings. The authors explain the treatment of seminoma and non-seminoma by stages. Carboplatin monotherapy is equivalent to the irradiation in early seminoma cases. Nowadays applied second and third line chemotherapies are reviewed. It is necessary to take into consideration not only the remission rate but also the late toxicity during the complex treatment of testicular germ cell cancer.

Published
2009
Full Text
View/download PDF

8. [Report from the 44th Congress of the American Society of Clinical Oncology].

Author

Baki M

Subjects
Antineoplastic Combined Chemotherapy Protocols administration & dosage, Biomarkers, Tumor, Brain Neoplasms therapy, Breast Neoplasms drug therapy, Camptothecin administration & dosage, Camptothecin analogs & derivatives, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Small Cell drug therapy, Chemotherapy, Adjuvant, Colorectal Neoplasms drug therapy, Female, Fluorouracil administration & dosage, Humans, Leucovorin administration & dosage, Lung Neoplasms drug therapy, Mass Screening, Neoplasms prevention & control, Organoplatinum Compounds administration & dosage, Societies, Medical, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Medical Oncology, Neoplasms diagnosis, Neoplasms therapy
Published
2008
Full Text
View/download PDF

9. [The results of ovarian cancer therapy in the Hungarian Centers in 2002-2003].

Author

Pulay T, Baki M, Bodoky G, Dank M, Cseh J, Csejtei A, Csömör S, Erfán J, Esik O, Faluhelyi Z, Izsó J, Hernádi Z, Kammerer K, Magyar T, Mayer A, Megyery E, Moskovits K, Pécsi L, Pikó B, Pintér T, Ruzsa A, Szánthó A, Szántó I, Szántó J, Szucs M, Tálos Z, Thurzó L, and Kásler M

Subjects
Adenocarcinoma, Mucinous therapy, Adult, Aged, Brenner Tumor therapy, Carboplatin administration & dosage, Carcinoma drug therapy, Carcinoma epidemiology, Carcinoma pathology, Carcinoma surgery, Carcinoma, Endometrioid therapy, Chemotherapy, Adjuvant, Cystadenocarcinoma, Serous therapy, Drug Administration Schedule, Female, Humans, Hungary epidemiology, Middle Aged, Ovarian Neoplasms drug therapy, Ovarian Neoplasms epidemiology, Ovarian Neoplasms pathology, Ovarian Neoplasms surgery, Paclitaxel administration & dosage, Retrospective Studies, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma therapy, Ovarian Neoplasms therapy, Ovariectomy
Abstract

Unlabelled: Authors presented data of treatment results and course of disease in 487 ovarian cancer patients treated by primary surgery and paclitaxel-carboplatin combination chemotherapy between July 1, 2002 and December 31, 2003., Patients: Most of our patients (87.8%) belonged to the age-group between 40-70 years. Distribution of their histological diagnosis was as 69.6% serous, 10.7% mucinous, 5.1% endometrial and 4.7% undifferentiated carcinoma. The grade distribution was found as 8.4% grade 1, 40.9% grade 2 and 35.9% grade 3., Results: The primary surgery was evaluated as optimal in 41.7%, suboptimal in 37.3% and exploration was performed in 21.1%. Most patients started chemotherapy 20 days after surgery and 74.2% of them got six courses. During the evaluation period 61 intervallum laparotomies were performed, and resulted on 55.7% optimal debulking. Complete remission was found in 58.9%, and partial remission in 14.7% of patients. This treatment resulted on a complete remission in 40.9% at the follow-up of 12 months.

Published
2006

10. [Status report on the chemotherapy of ovarian cancer at special cancer centers in Hungary (2002-2003)].

Author

Pulay T, Baki M, Bodoky G, Dank M, Cseh J, Csejtei A, Csömör S, Erfán J, Esik O, Faluhelyi Z, Izsó J, Hernádi Z, Kammerer K, Krommer K, Magyar T, Mayer A, Megyery E, Moskovits K, Pécsi L, Pikó B, Pintér T, Ruzsa A, Szánthó A, Szántó I, Szántó J, Szucs M, Tálos Z, Thurzó L, and Kásler M

Subjects
Adolescent, Adult, Aged, Aged, 80 and over, Antibiotics, Antineoplastic administration & dosage, Antineoplastic Agents, Phytogenic administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cancer Care Facilities statistics & numerical data, Docetaxel, Doxorubicin administration & dosage, Female, Humans, Hungary, Middle Aged, Neoplasm Staging, Ovarian Neoplasms pathology, Ovarian Neoplasms surgery, Ovariectomy, Paclitaxel administration & dosage, Retrospective Studies, Taxoids administration & dosage, Topotecan administration & dosage, Treatment Outcome, Antineoplastic Agents therapeutic use, Ovarian Neoplasms drug therapy
Abstract

Data on the first-line treatment of ovarian cancer in special centers of Hungary 2002 and 2003 are presented, involving 283 and 416 patients, respectively. Patients' age, clinical stage and histological type of the tumor were highly similar to literature data, while grades were different. Surgical effectiveness in case of IIIc staged tumors with >1 cm residual mass was 37%. The ratio of interval laparotomy was about 15%. Overall response rates of the first-line treatment of ovarian cancer was 82%, while the rate of complete remissions was 60%. The authors provide detailed analysis of factors that can improve the chemotherapy of ovarian cancer in Hungary.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results